Make Informed Investment Decisions with Affordable Access to Experts

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Fridays with Adam Feuerstein #2 - Discussing Gottlieb, FOURIER data, and AF's Biotech Bear Case

Ticker(s): AMGN, MDCO, IONS, REGN, AZN, AVXS, CLVS, TSRO, ALNY

Who's the expert?

Name: Adam Feuerstein

Adam Feuerstein is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. A veteran journalist, Adam was most recently Senior Columnist at TheStreet, where he wrote about biotech and drug stocks. Adam lives near Boston with his wife, two kids and Bo, an insanely cute boxer/mutt.

Interview Questions
Q1.

Join now and add your questions for Adam F.! 

Added By: joe_mccann
Q2.

Your opinion on  BLCM?

Added By: aklapholz
Q3.

STML?

Added By: biohunter

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.